Dossier
PCSK9 inhibitor
Coverage of PCSK9 inhibitor in the Nexus archive.
- FDA approves new kind of cholesterol pill
The FDA has approved the first oral PCSK9 inhibitor to lower LDL cholesterol in adults with high cholesterol. This new cholesterol pill represents a novel treatment option for managing elevated cholesterol levels.
- Drugmaker Merck announces approval of new cholesterol-fighting drug
Merck received FDA approval for Lipfendra, a PCSK9 inhibitor that serves as an alternative to statins for managing high LDL cholesterol. Statins, while widely prescribed, can cause side effects like muscle aches and may not sufficiently lower cholesterol levels for some patients.